Phil Wilson

Phil Wilson is a highly accomplished finance professional currently serving as the Vice President of Corporate Finance at Biosplice Therapeutics. He has a strong background in corporate finance and development, with extensive experience in leadership roles across various reputable organizations.1

Education and Early Career

Phil holds a BA in Economics and History from Bowdoin College, which he attended from 2004 to 2008. Prior to his college education, he completed his high school studies at Episcopal Academy from 2000 to 2004.1

Wilson began his career as an Analyst in the Investment Banking Division at Credit Suisse, where he worked from 2008 to 2010.1 This role provided him with a solid foundation in financial analysis and strategic decision-making.

Professional Journey

After his stint at Credit Suisse, Phil's career progressed through several notable positions:

1. Intervale Capital: He held multiple roles, including Associate (2011-2013), Senior Associate (2013-2014), and Vice President (2014-2015).1

2. Oaktree Capital Management: Phil served as a Vice President from 2015 to 2016.1

3. Biosplice Therapeutics: Wilson joined the company in 2016 and has since held several positions:

   • Director of Corporate Development
   • Senior Director of Corporate Development
   • Vice President of Corporate Finance (current role)

Skills and Expertise

Throughout his career, Phil Wilson has demonstrated expertise in:

• Corporate finance
• Corporate development
• Investment management
• Financial analysis
• Strategic decision-making

His diverse experience across various financial roles has equipped him with a comprehensive skill set, making him a valuable asset in his current position at Biosplice Therapeutics.